Uterine Arteriovenous Malformation: Induced by A Cesarean Scar Pregnancy

2013 ◽  
Vol 24 (1) ◽  
pp. 55-60 ◽  
Author(s):  
Lin ZHUANG ◽  
De-xin CHEN ◽  
Yue-hong YAO
2011 ◽  
Vol 39 (9) ◽  
pp. 534-538 ◽  
Author(s):  
Ozgur Akbayir ◽  
Ali Gedikbasi ◽  
Alpaslan Akyol ◽  
Adem Ucar ◽  
Sezin Saygi-Ozyurt ◽  
...  

2013 ◽  
Vol 52 (4) ◽  
pp. 590-592 ◽  
Author(s):  
Doa Kim ◽  
Na Rae Moon ◽  
Su Rim Lee ◽  
Yu Dong Won ◽  
Hee Joung Lee ◽  
...  

Medicine ◽  
2020 ◽  
Vol 99 (31) ◽  
pp. e21432
Author(s):  
Xiangjuan Li ◽  
Wenchao Sun ◽  
Lingna Chen ◽  
Mei Jin ◽  
Zhifen Zhang ◽  
...  

Author(s):  
Sangam Jha ◽  
Akanksha Singh

Objective: Arteriovenous malformation (AVM) can occur in cesarean scar ectopic pregnancy. The presence of retained product of conception can pose a diagnostic dilemma and clinical presentation could be similar. Case report: A 27 year old female presented with continuous vaginal bleeding for two and half months following dilatation and evacuation (D&E) done for cesarean scar pregnancy (CSP) of 10 weeks 4days period of gestation. Sonography with color Doppler revealed dilated tortuous vessels around the mass in lower uterine segment suggesting CSP with AVM. Digital subtraction angiography confirmed the diagnosis. Bilateral uterine artery embolization achieved complete devascularisation as confirmed on post intervention angiogram. Patient became symptom free since then. Conclusion: Uterine artery embolization is an effective mode of treatment of AVM complicating CSP if future fertility is desired.


Author(s):  
Joana Cominho ◽  
Inês Azevedo ◽  
Sofia Saramago ◽  
Ana Brandão ◽  
Isabel Serrano ◽  
...  

2011 ◽  
Vol 31 (4) ◽  
pp. 450-452
Author(s):  
Yu-huan LIU ◽  
Ning HUI ◽  
Ming-juan XU ◽  
Hui ZHANG ◽  
Rui GUAN ◽  
...  

Author(s):  
Omer Tammo ◽  
Hacer Uyanikoglu ◽  
İsmail Koyuncu

Aim and Objective: This study aimed to explore the plasma free amino acid (FAA) and carnitine levels in pregnant women with cesarean scar pregnancy (CSP), and to compare them with those of healthy pregnant women. Materials and Methods: This prospective and randomized controlled study was conducted in patients admitted to Harran University Medical Faculty Hospital Obstetrics Clinic between January 2018 and January 2019. A total of 60 patients were included in the study, and the patients were divided into two groups: CSP group (n = 30) and healthy pregnant group as the control group (n = 30). The blood samples were taken from the participants between 7 - 12 weeks of gestation. Twentyseven carnitines and their esters and 14 FAAs were analysed by liquid chromatography – mass spectrometry (LC-MS/MS). Results: The mean plasma concentrations of some carnitines, including C2, C5, C5-OH, C5-DC, C6, C8-1, C12, C14, C14- 1, C14-2, C16, C16-1, C18, and C18-1 were significantly higher in CSP group than in the control group. However, other carnitines, including C0, C3, C4, C4-DC, C5-1, C6-DC, C8, C8-DC, C10, C10-1, C18-1-OH, and C18-2 were similar in both groups. The plasma levels of some FAAs, including Methyl Glutaryl, Leu, Met, Phe, Arg, Orn, and Glu values were significantly higher in CSP group than in the control group. However, there was no statistically significance in other FAA levels, including Val, Asa, Tyr, Asp, Ala, Cit, and Gly between the two groups. Additionally, Pearson’s correlation analysis showed that there were significantly positive correlations between many FAA and carnitine values. Conclusion: Since several plasma carnitine and FAA levels were higher in CSP group than in the control group, we think that scar pregnancy increases metabolic need for myometrial invasion. Also, we think that these results may be useful in clinical practice for CSP diagnosis.


Sign in / Sign up

Export Citation Format

Share Document